Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-25-000487
Filing Date
2025-04-30
Accepted
2025-04-30 10:58:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4586
  Complete submission text file 0000932471-25-000487.txt   6251
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Subject) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92726 | Film No.: 25891962
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)